Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Chrysalis begins clinical evaluation of wound-healing agent

Sep. 30, 1998

Gliatech reports promising pilot clinical trial results with ADCON-P

Sep. 29, 1998

Fujisawa concludes agreement for development of calcipotriol

Sep. 28, 1998

Topical SDZ-ASM-981 is effective in treating atopic dermatitis

Sep. 28, 1998

Vanguard discontinues development of psoriasis drugs

Sep. 25, 1998

Novel use for a known antidepressant: doxepin relieves pruritus in patients with eczema

Sep. 18, 1998

FDA accepts Dusa's NDA for filing

Sep. 15, 1998

AEterna releases interim phase I/II data for Psovascar

Sep. 14, 1998

Immune Response presents phase II data on psoriasis treatment

Sep. 11, 1998

RXR/RAR receptor modulators claimed by CIRD Galderma for skin and other disorders

Sep. 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.